Xsphera Biosciences is a Boston-based biotechnology startup focused on delivering functional, precision immuno-oncology solutions for drug development and patient care. The company's patented science, originally developed at the Dana-Farber Cancer Institute, captures each patient's unique tumor microenvironment on a chip for profiling responses to multiple therapeutics. Our ex vivo platform enables drug developers and providers to move forward with confidence.